vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -12.9%, a 13.8% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -0.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-680.1M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 22.1%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
FOLD vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $340.0M |
| Net Profit | $1.7M | $-13.9M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | -17.2% |
| Net Margin | 0.9% | -12.9% |
| Revenue YoY | 23.7% | -0.4% |
| Net Profit YoY | -88.5% | -131.0% |
| EPS (diluted) | $0.00 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $340.0M | ||
| Q3 25 | $169.1M | $337.7M | ||
| Q2 25 | $154.7M | $319.2M | ||
| Q1 25 | $125.2M | $237.4M | ||
| Q4 24 | $149.7M | $341.5M | ||
| Q3 24 | $141.5M | $292.3M | ||
| Q2 24 | $126.7M | $270.7M | ||
| Q1 24 | $110.4M | $228.1M |
| Q4 25 | $1.7M | $-13.9M | ||
| Q3 25 | $17.3M | $33.5M | ||
| Q2 25 | $-24.4M | $34.0M | ||
| Q1 25 | $-21.7M | $2.8M | ||
| Q4 24 | $14.7M | $44.8M | ||
| Q3 24 | $-6.7M | $28.8M | ||
| Q2 24 | $-15.7M | $22.7M | ||
| Q1 24 | $-48.4M | $11.9M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | -17.2% | ||
| Q3 25 | 20.3% | 13.6% | ||
| Q2 25 | -6.1% | 14.5% | ||
| Q1 25 | -6.3% | 2.2% | ||
| Q4 24 | 10.7% | 15.3% | ||
| Q3 24 | 15.3% | 12.8% | ||
| Q2 24 | 11.8% | 10.4% | ||
| Q1 24 | -25.1% | 6.0% |
| Q4 25 | 0.9% | -12.9% | ||
| Q3 25 | 10.2% | 9.9% | ||
| Q2 25 | -15.8% | 10.6% | ||
| Q1 25 | -17.3% | 1.2% | ||
| Q4 24 | 9.8% | 13.1% | ||
| Q3 24 | -4.8% | 9.9% | ||
| Q2 24 | -12.4% | 8.4% | ||
| Q1 24 | -43.9% | 5.2% |
| Q4 25 | $0.00 | $-0.41 | ||
| Q3 25 | $0.06 | $0.98 | ||
| Q2 25 | $-0.08 | $0.99 | ||
| Q1 25 | $-0.07 | $0.08 | ||
| Q4 24 | $0.05 | $1.32 | ||
| Q3 24 | $-0.02 | $0.85 | ||
| Q2 24 | $-0.05 | $0.67 | ||
| Q1 24 | $-0.16 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $299.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.7B |
| Total Assets | $949.9M | $5.1B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $299.3M | ||
| Q3 25 | $263.8M | $274.8M | ||
| Q2 25 | $231.0M | $233.7M | ||
| Q1 25 | $250.6M | $181.0M | ||
| Q4 24 | $249.9M | $279.3M | ||
| Q3 24 | $249.8M | $179.8M | ||
| Q2 24 | $260.1M | $208.1M | ||
| Q1 24 | $239.6M | $216.5M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $1.7B | ||
| Q3 25 | $230.4M | $1.8B | ||
| Q2 25 | $204.3M | $1.8B | ||
| Q1 25 | $193.6M | $1.7B | ||
| Q4 24 | $194.0M | $1.7B | ||
| Q3 24 | $178.8M | $1.7B | ||
| Q2 24 | $132.5M | $1.7B | ||
| Q1 24 | $130.7M | $1.7B |
| Q4 25 | $949.9M | $5.1B | ||
| Q3 25 | $868.8M | $5.8B | ||
| Q2 25 | $815.3M | $4.7B | ||
| Q1 25 | $789.8M | $4.5B | ||
| Q4 24 | $785.0M | $4.4B | ||
| Q3 24 | $786.6M | $4.6B | ||
| Q2 24 | $749.5M | $4.2B | ||
| Q1 24 | $721.8M | $3.8B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $-664.3M |
| Free Cash FlowOCF − Capex | $16.0M | $-680.1M |
| FCF MarginFCF / Revenue | 8.6% | -200.0% |
| Capex IntensityCapex / Revenue | 0.2% | 4.6% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $-664.3M | ||
| Q3 25 | $35.7M | $-948.1M | ||
| Q2 25 | $-26.5M | $-238.5M | ||
| Q1 25 | $7.8M | $-281.1M | ||
| Q4 24 | $-3.9M | $129.4M | ||
| Q3 24 | $-23.0M | $-202.0M | ||
| Q2 24 | $22.7M | $-237.8M | ||
| Q1 24 | $-29.7M | $38.4M |
| Q4 25 | $16.0M | $-680.1M | ||
| Q3 25 | $35.3M | $-950.4M | ||
| Q2 25 | $-28.9M | $-241.0M | ||
| Q1 25 | $7.5M | $-284.7M | ||
| Q4 24 | $-4.2M | $116.4M | ||
| Q3 24 | $-23.3M | $-204.0M | ||
| Q2 24 | $21.6M | $-241.7M | ||
| Q1 24 | $-31.5M | $35.2M |
| Q4 25 | 8.6% | -200.0% | ||
| Q3 25 | 20.9% | -281.5% | ||
| Q2 25 | -18.7% | -75.5% | ||
| Q1 25 | 6.0% | -120.0% | ||
| Q4 24 | -2.8% | 34.1% | ||
| Q3 24 | -16.5% | -69.8% | ||
| Q2 24 | 17.0% | -89.3% | ||
| Q1 24 | -28.5% | 15.4% |
| Q4 25 | 0.2% | 4.6% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | 1.6% | 0.8% | ||
| Q1 25 | 0.2% | 1.5% | ||
| Q4 24 | 0.2% | 3.8% | ||
| Q3 24 | 0.3% | 0.7% | ||
| Q2 24 | 0.9% | 1.4% | ||
| Q1 24 | 1.6% | 1.4% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | -28.34× | ||
| Q2 25 | — | -7.02× | ||
| Q1 25 | — | -102.07× | ||
| Q4 24 | -0.27× | 2.89× | ||
| Q3 24 | — | -7.01× | ||
| Q2 24 | — | -10.49× | ||
| Q1 24 | — | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
WD
Segment breakdown not available.
